Modulated electro-hyperthermia induced loco-regional and systemic tumor destruction in colorectal cancer allografts
/in Colorectal Cancer, Hyperthermia, International PublicationsPhase I clinical trial of a novel autologous modified-DC vaccine in patients with resected NSCLC
/in Dendritic Cells, International Publications, NSCLCAntitumor Benefits of Antiviral Immunity: An Underappreciated Aspect of Oncolytic Virotherapies
/in International Publications, Newcastle Disease VirusAutologous Dendritic Cells Pulsed with Allogeneic Tumor Cell Lysate in Mesothelioma: From Mouse to Human
/in Dendritic Cells, International Publications, Malignant Pleural MesotheliomaAdvances in immunotherapeutic research for glioma therapy
/in Dendritic Cells, Glioblastoma, International PublicationsImmunotherapy in pancreatic ductal adenocarcinoma: an emerging entity?
/in International Publications, Pancreatic CancerThe clinical benefit of hyperthermia in pancreatic cancer: a systematic review
/in Hyperthermia, International Publications, Pancreatic CancerAn update on the relevance of vaccine research for the treatment of metastatic melanoma
/in Dendritic Cells, International Publications, Malignant MelanomaClinical and economic evaluation of modulated electrohyperthermia concurrent to dose-dense temozolomide 21/28 days regimen in the treatment of recurrent glioblastoma: a retrospective analysis of a two-centre German cohort trial with systematic comparison and effect-to-treatment analysis
/in Glioblastoma, Hyperthermia, International Publications
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Die IOZK Immuntherapie
Aktuelles und Int. Publikationen
- WT1-mRNA dendritic cell vaccination of patients with glioblastoma multiforme, malignant pleural mesothelioma, metastatic breast cancer, and other solid tumors: type 1 T-lymphocyte responses are associated with clinical outcome
- Autologous tumor lysate-loaded dendritic cell vaccination in glioblastoma patients: a systematic review of literature
- Retrospective Analysis of HLA Class II-Restricted Neoantigen Peptide-Pulsed Dendritic Cell Vaccine for Breast Cancer